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Objectives: Prosthodontic rehabilitation using dental implants has become a common practice in dentistry at the 
present time. Although severe complications related to dental osseointegrated implants are uncommon, in recent 
years several cases of oral squamous cell carcinoma adjacent to dental implants have been published.
Study Design: A 67-year-old edentulous woman developed an oral squamous cell carcinoma around right mandi-
bular implant about 12 months after receiving dental implants. The treatments involve chemotherapy, explantation 
of the implants and radiotherapy.
Result and Conclusions: The use of endosseous implants has been associated with a low risk for the development 
of cancer. However, this case report serves as evidence to the importance of careful screening at routine dental exa-
minations especially if the patient suffers from peri-implantitis, any mucosal erosion or discoloration, leukoplakia 
around implant, pain, implant loosening, bone loss around implant, mucosal erythema, and soft tissue inflamma-
tion.
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Introduction
Endosseous dental implants have become a predictable 
and common practice for the replacement of missing tee-
th. The overall success rate for dental implants is more 
than 90 percent (1). A wide variety of metallic, ceramic, 
and polymeric synthetic biomaterials have been used for 
prosthetic implants in the human body. Both the safety 
and effectiveness of this technique have been extensi-
vely demonstrated in the literature (2). Nevertheless, the 
number of complications associated to dental implants 
has increased proportionally to the popularization of its 
employment (3). Complications, which are uncommon, 
include postoperative infection, peri-implantitis, im-
plant fracture, bone loss, and failure of osseointegration 
with loosening of the implant. Recently, some reports 
have also been published about primary squamous cell 
carcinoma of oral mucosa (4-7), primary osteosarcoma 
in jaws (8), and metastatic carcinoma (9) in the vicinity 
of the implants.
The case report we present here describes a patient with 
squamous cell carcinoma around her dental implants. 
Case Report
A diabetic 67-year-old woman sought treatment for 
pain and swelling of four months duration involving 
the right mandible in the distal area of the canines. 15 
years previously the patient started wearing full den-
ture. 16 months ago she referred to a dentist in order 
to fix her loose denture and she also complained from 
denture induced alveolar mucosal inflammation in the 
right mandible. Her dentist surgically placed two 6.0 
× 13 millimeter dental implant (Nobel Biocare, Göte-
borg, Sweden) in the edentulous canines’ area of the 
mandible; afterwards, the dentist placed the overdenture 
abutments onto the implants. (Figure 1) 12 months after 
the implants insertion she started having pain in the right 
mandibular canine area; which was so aggravating that 
prevented her from wearing her overdenture. Her dentist 
prescribed antibiotics; however, when the lesion did not 
respond to initial antibiotic therapy, the patient’s dentist 
performed an incisional biopsy to establish a definitive 
diagnosis. Thus, she was referred to the oral and maxi-
llofacial pathology department of a dental school for a 
more definitive diagnosis and treatment. She had had the 
lesions for two months. A fellow of orthognathic surgery 
recorded her medical and dental history, which included 
no smoking or alcohol consumption; however, she suffe-
red from diabetes and high blood pressure both of which 
were under medical control. An exophytic mucosal mass 
overlying alveolar mucosa and extending from anterior 
floor of mouth to ventral surface of the tongue was appa-
rent. (Fig. 1) Peri-implantitis, implant loosening, muco-
sal erythema, inflammation of the soft tissue, and bone 
loss around right mandibular implant were evident.  The 
right submandibular lymph nodes were easily palpable 
by finger touch. An excisional biopsy was performed 
and the tissue was submitted for pathological evaluation 
to the department of oral and maxillofacial pathology.
Pathological findings: Microscopic examination of the 
submitted biopsy specimen revealed a moderately diffe-
rentiated squamous cell carcinoma showing hyperchro-
matism of the nuclei, keratin pearl formation, pleomor-
phism, and numerous mitotic figures (Figures 2, 3). 
Fig. 1. Intra oral photo of the patient
Fig. 2. A, Section from the biopsy taken of the oral lesion (magni-
fication ×4)
Fig. 3. A, Section from the biopsy taken of the oral lesion (magni-
fication ×40)
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plant placement to the development of osteosarcoma has 
ranged from six months to 30 years, with a mean of nine 
years. (8)
In this case report we have presented an unusual patient 
who developed a SCC adjacent to a mandibular implant. 
The lesion described in this report initially was confused 
with peri-implantitis. In implant patients or implant can-
didates who suffer from peri-implantitis, any mucosal 
erosion or discoloration, leukoplakia around implant, 
pain, implant loosening, bone loss around implant, mu-
cosal erythema, and soft tissue inflammation regular fo-
llow-up and careful exploration of the area is essential
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Therapy: The patient received three initial courses of 
chemotherapy. Afterwards, the implants were explanted 
immediately. The tumor along with some local blood 
vessels and muscles were removed by pull-through te-
chnique. 34 lymph nodes were also removed, 3 of which 
were metastatic. The patient was then scheduled for ra-
diotherapy. 
Discussion
The development of neoplasia associated with alloplas-
tic implant materials is a rare complication that a number 
of clinicians and researchers have reported, primarily in 
the orthopedic literature (10-11).
Although the materials composing these implants are re-
latively biologically inert and nontoxic they may induce 
a variety of tissue responses (12). By far the most serious 
complication of orthopaedic hardware and prosthetic 
material is malignancy. Animal studies analyzing the 
biological effects of the components of prosthetic joints 
revealed carcinogenic properties of beryllium, cadmium, 
chromium, cobalt, iron, lead, nickel, selenium, zinc, and 
titanium (13). In humans, prostheses containing cobalt, 
chromium, stainless steel, nickel, iron, manganese and 
silicon have been implicated as being carcinogenic. 
Other authors state that the placement of an implant may 
induce osteonecrosis, which in itself is a risk factor for 
the development of a sarcoma (8, 14). 
Dental implants have also been of no exception. An elec-
tronic review of the literature suggests that an exhausti-
ve differential diagnosis is required in implant patients 
who refer to dentist complaining from lesions, severe 
pain, halitosis, swelling and gum irritation, implant mo-
bility, and numbness or paresthesia (1-9). Sometimes, 
the initial clinical appearance of lesions suggested peri-
implantitis (7) with a red, hyperplasic or even ulcerated 
appearance while the patient was suffering from cancer. 
Detection of the oral lesions has great importance as 
they may be diagnosed first by the patient’s dentist or 
by the maxillofacial surgeon. The lesion can indicate the 
presence of a primary squamous cell carcinoma, osteo-
sarcoma and metastasis (9).  Metastatic tumors of the 
jaws, from distant organs and tissues, may be diagnosed 
first by the oral surgeon, and most of the patients with 
oral metastasis may have seen another dentist recently 
but the condition has not been diagnosed (15).
Chronic inflammation, smoking and alcohol consump-
tion as well as premalignant lesions and conditions such 
as leukoplakia, and oral lichen planus (OLP), have been 
recognized to be risk factors for the development of ma-
lignancy. It has also been reported that the majority of all 
presented cases had at least one recognized risk factor 
for oral cancer (4).
McGuff et al. have reported that there appears to be re-
lation between implant-related sarcomas and sex of the 
patients. They also reported that the interval from im-
